MTAP and lymphoma: MTAP-inactivating mutations are also associated with an autosomal-dominant bone dysplasia and cancer syndrome in humans, and MTAP heterozygous knockout in mice is sufficient to cause lymphoma, indicating that MTAP itself is a tumor suppressor (Kadariya et al. 2009, Camacho-Vanegas et al. 2012).